Clinical Trial Update: Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug [Phase 2]

View source ↗

Summary

This update reports the termination of a Phase 2 trial evaluating an immunostimulatory drug for ragweed-induced asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Seasonal Allergic Rhinitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Allergy | Phase 2 | Status: TERMINATED